About Foslevodopa,Foscarbidopa
            
            Class: | Combination of a prodrug of levodopa (Foslevodopa) and a dopa decarboxylase inhibitor (Foscarbidopa)  
Use: | Treatment of motor symptoms in adults with Parkinson's disease  
Adult dose: | 240 mg/1 ml of Foslevodopa and 12 mg/1 ml of Foscarbidopa administered as an infusion, dosage may vary based on individual response and clinical condition  
Pediatric dose: | Safety and efficacy not established in pediatric populations; not recommended for use in children  
Side effects: | Common side
         
        
            
                
                
                    
                        Drug Class
                    
                    Combination of a prodrug of levodopa (Foslevodopa) and a dopa decarboxylase inhibitor (Foscarbidopa)
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of motor symptoms in adults with Parkinson's disease
                 
                
                
                    
                        Storage Requirements
                    
                    Store at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Abbvie Corporation [Quebec;Canada], Canada
                    
                    
                    Package Size
                    7 Glass Vials (10 mL)
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 5890.50
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        240 mg/1 ml of Foslevodopa and 12 mg/1 ml of Foscarbidopa administered as an infusion, dosage may vary based on individual response and clinical condition
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric populations; not recommended for use in children
                    
                 
                
                
                    
                        Side Effects
                    
                    Common side effects include nausea, vomiting, dizziness, orthostatic hypotension, dyskinesia, and headache
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to Foslevodopa, Foscarbidopa, or any component of the formulation; concurrent use with non-selective MAO inhibitors; narrow-angle glaucoma; history of melanoma
         
        
        
            
                Important Warnings
            
            Risk of sudden onset of sleep; may cause impulse control disorders; monitor for signs of dyskinesia; caution in patients with cardiovascular disease, psychiatric disorders, or a history of melanoma
         
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.